Inventor
EHARA TAKERU
JP16 patents
⚠️ This page may combine multiple inventors who share the name “EHARA TAKERU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
5 patentsUS10093663B2Oct 9, 2018
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
NOVARTIS AG5 citations72
US10316020B2Jun 11, 2019
Indane derivatives and the use thereof as soluble guanylate cyclase activators
NOVARTIS AG0 citations51
US10550102B2Feb 4, 2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
NOVARTIS AG0 citations49
US8383650B2Feb 26, 2013
Organic compounds
NOVARTIS AG0 citations49
US7704996B2Apr 27, 2010
Compounds and compositions useful as cathepsin S inhibitors
NOVARTIS AG1 citations48
ADAMS CHRISTOPHER MICHAEL
3 patentsUS9056874B2Jun 16, 2015
Complement pathway modulators and uses thereof
ADAMS CHRISTOPHER MICHAEL95 citations96
US9682968B2Jun 20, 2017
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
ADAMS CHRISTOPHER MICHAEL15 citations83
US9475806B2Oct 25, 2016
Complement factor B inhibitors and uses there of
ADAMS CHRISTOPHER MICHAEL6 citations71
ADAMS CHRISTOPHER M
3 patentsUS10208018B2Feb 19, 2019
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations48
US9765067B2Sep 19, 2017
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations38
US9957254B2May 1, 2018
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations36